Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Bill Steinman
Contributing Editor

Job: Regional Ethics & Compliance Officer – Europe, Middle East & Africa (EMEA)

Job Title: Regional Ethics & Compliance Officer – Europe, Middle East & Africa (EMEA)

Employer: Cognizant

Location: London or Amsterdam

Description: Based in London or Amsterdam, our RECO-EMEA, with support from several direct reports and other legal and compliance specialists, will be an integral member of our RECO network.  The RECO-EMEA will work closely with the business leaders and key corporate functions to understand and mitigate E&C risks in EMEA, implement our E&C program in EMEA, and provide counseling in EMEA, with minimal oversight .Continue Reading

Israel arms exports will require KYC and sanctions checks

The agency in charge of granting licenses to defense exporters will start to require KYC, blacklist, and sanctions searches to applications for marketing and export licenses. This move is meant to strengthen control by Israeli authorities over marketing and export of military goods, which sometimes allegedly find their way into dubious hands.… Continue Reading

UK ends graft investigations of GSK and individuals at Rolls-Royce

The UK Serious Fraud Office said Friday it has closed bribery investigations into UK-based GlaxoSmithKline PLC and individuals at subsidiaries of Rolls-Royce Holdings PLC.

SFO director Lisa Osofsky said in a statement there was “either insufficient evidence to provide a realistic prospect of conviction or it is not in the public interest to bring a prosecution in these cases.”

In a response filed with the London Stock Exchange, GSK said it was “pleased that the SFO have closed their investigation and concluded that no further action is required.”

In 2016, London-based GSK paid the U.S.… Continue Reading